|
Title
|
Published
|
Price
|
|
Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis
By: GBI Research
Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis Summary GBI Research, the leading business intelligence provider, has released its latest research “Stem Cell Research - Market Trends, Investment Trends and Pipeline Analysis”. It is
|
more...
|
2/1/2010
|
$3,500.00
|
|
Biomarkers, Tests and Trends for Drug R&D
By: Takeda Pacific
This report is about the world market for biomarkers and tests used for drug R&D. The study reviews and analyzes the market by examining biomarker related drug R&D spending, trends, major diseases, applications, M&As, alliances,
|
more...
|
2/1/2010
|
$2,400.00
|
|
Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape
By: GBI Research
Small and Medium Biopharmaceutical Enterprises in North America and Europe - Biotechnology Clusters, Funding Characteristics and Regulatory Landscape Summary GBI Research, the leading business intelligence provider, has released its latest research, “Small and Medium Biopharmaceutical Enterprises in
|
more...
|
2/1/2010
|
$3,500.00
|
|
Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma
By: GBI Research
Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs in Pharma Summary GBI Research, the leading business intelligence provider, has released its latest research “Ribonucleic Acid (RNA) Therapeutics - Strong Potential to Address Unmet Needs
|
more...
|
2/1/2010
|
$3,500.00
|
|
Biotech Business - February 2010
By: Worldwide Videotex
Biotech Business provides detailed information on
biotechnology products and companies. It reports which
universities offer licensing of biotechnology research, which companies have entered licensing agreements, as well as the financial health of biotechnology companies
|
more...
Search inside this report
|
2/1/2010
|
$25.00
|
|
Biotech Equipment Update - February 2010
By: Worldwide Videotex
Biotech Equipment Update covers news and the latest
information about biotechnology lab and manufacturing
equipment and products. This includes new product and
technology announcements, as well as vendor research,
development, and manufacturing
|
more...
Search inside this report
|
2/1/2010
|
$25.00
|
|
Biotech Financial Reports - February 2010
By: Worldwide Videotex
Biotech Financial reports provides the latest financial
information and news on biotech and pharmaceutical companies.
This includes quarterly and annual reports plus merger and
acquisition news, and stock dividend
|
more...
Search inside this report
|
2/1/2010
|
$25.00
|
|
Worldwide Biotech - February 2010
By: Worldwide Videotex
Worldwide Biotech provides news and information on
biotechnology as an international industry, reporting on the
deals between U.S. biotechnology companies and international
pharmaceutical corporations. Monitors the emerging
European Community marketplace and the growing Japanese
|
more...
Search inside this report
|
2/1/2010
|
$25.00
|
|
Investing in Stem Cell Companies in 2010 and Beyond
By: BioPolaris
Stem cell market is on the brink of explosion. The first approval of stem cell-based therapeutic product will push
the whole market forward not only financially but also acceptance of stem cells as the mode
|
more...
Search inside this report
|
2/1/2010
|
$3,250.00
|
|
Brief Report: Interleukin-17 (IL-17R) and IL-17 Receptor Antagonists
By: La Merie S.L.
The present Brief Report about molecules targeting interleukin-17 (IL-17) or its receptor provides an assessment, competitor evaluation and detailed profiles of antibodies and other molecules in development. R&D projects of primarily antibodies targeting IL-17 or
|
more...
Search inside this report
|
2/1/2010
|
$697.00
|
|
SNP Genotyping and Analysis Markets
By: Kalorama Information
Because SNPs (single nucleotide polymorphisms),are the most common type of genetic variation between human beings. These single base pair mutations at specific DNA sequence sites, can be ideal for the task of
|
more...
Search inside this report
|
2/1/2010
|
$3,995.00
|
|
Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline
By: GBI Research
Summary
GBI Research, the leading business intelligence provider, has released its latest research, “Top 10 Biotechnology Companies - SWOT Analysis, Competitive Benchmarking, Financial Analysis and R&D Pipeline”, which provides an insight into the global
|
more...
|
2/1/2010
|
$3,500.00
|
|
Biomarkers in Drug Discovery - Optimizing Drug Discovery Timeline and Costs
By: GBI Research
Summary
GBI Research, the leading business intelligence provider, has released its latest research, “Biomarkers In Drug Discovery - Optimizing Drug Discovery Timeline and Costs”. The report provides an in-depth analysis of the potential applications
|
more...
|
2/1/2010
|
$3,500.00
|
|
Patent map and technology intelligence report. Fermentation/Enzyme-using Processes To Synthesize Compounds Or Separate Optical Isomers From Racemic Mixture
By: Intellectual Property Exchange
Preparation of compounds or compositions, by using micro-organisms or enzymes; General processes for the preparation of compounds or compositions by using micro-organisms or enzymes; Preparation of elements or inorganic compounds except carbon dioxide; Preparation of
|
more...
|
1/24/2010
|
$1,200.00
|
|
Patent map and technology intelligence report. Preservation Of Bodies Of Humans Or Animals Or Plants Or Parts Thereof; Biocides
By: Intellectual Property Exchange
Preservation of bodies of humans or animals, or parts thereof; Preservation of plants or parts thereof, e.g. inhibiting evaporation, improvement of the appearance of leaves; Grafting wax; Biocides, pest repellants or attractants, or plant growth
|
more...
|
1/24/2010
|
$1,200.00
|
|
Innovation in Science & Technology Key Recent Media Coverage, January 2010
By: TecTrends Reporter
Scientific and technological innovation has produced an endless array of developments that radically changed the world. Information about research and development in science and technology is crucial to a wide range of individuals, including
|
more...
|
1/20/2010
|
$79.95
|
|
Analytical Tool - Apoptosis in Oncology
By: BioSeeker Group AB
Analytical Tool - Apoptosis in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in apoptopic drug development for the treatment of cancer. It is at the same
|
more...
|
1/20/2010
|
$4,495.00
|
|
Analytical Tool - Protein Kinase Inhibitors in Oncology
By: BioSeeker Group AB
Analytical Tool - Protein Kinase Inhibitors in Oncology" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in the drug development of protein kinase inhibitors (PKIs) for the treatment
|
more...
|
1/20/2010
|
$5,148.00
|
|
Company Financials: Human Genome Sciences, Inc.
By: Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet,
|
more...
|
1/20/2010
|
$75.00
|
|
Protein Kinase Inhibitors in Oncology: Drug Pipeline Update 2010
By: BioSeeker Group AB
Protein kinase inhibitors such as Gleevec, Iressa and Tarceva have allowed the biotechnology industry to deliver on the promise of targeted cancer drugs. However, these three successful drugs are just the top of an emerging
|
more...
|
1/20/2010
|
$2,174.00
|
|
Company Financials: ImmunoGen, Inc.
By: Datamonitor
Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies. The datapack covers wealth of financial information relating to income statement, balance sheet,
|
more...
|
1/20/2010
|
$75.00
|
|
Immunotherapy in Oncology: Drug Pipeline Update 2010
By: BioSeeker Group AB
Cancer immunotherapy offers an attractive therapeutic addition, delivering treatment of high specificity, low toxicity and prolonged activity. In this Drug Pipeline Update BioSeeker brings together the fields of antibodies, vaccines, and immunostimulators in oncology drug
|
more...
|
1/20/2010
|
$3,553.00
|
|
Analytical Tool - The Commercial Success of Cancer Therapeutic Antibodies
By: BioSeeker Group AB
Analytical Tool - Cancer Therapeutic Antibodies" offers a unique tool for analyzing the vast amount of strategic possibilities that have emerged in antibody drug development for the treatment of cancer. It is at the same
|
more...
|
1/20/2010
|
$5,799.00
|
|
Antibodies in Oncology: Drug Pipeline Update 2010
By: BioSeeker Group AB
The commercial and therapeutic success of antibodies like Rituxan, Avastin, and Erbitux will force the industry to look into the next generation of therapeutic antibodies, preparing themselves for the second wave in the lucrative field
|
more...
|
1/20/2010
|
$2,174.00
|
|
Apoptosis in Oncology: Drug Pipeline Update 2010
By: BioSeeker Group AB
Cancer cells frequently and possibly invariably possess apoptotic defects. In this context, apoptotic pathways provide exciting molecular targets for new therapeutic agents to specifically promote apoptosis of cancer cells.
There are today 226 (189) companies
|
more...
|
1/20/2010
|
$2,174.00
|
|
Title
|
Published
|
Price
|
(0 items)
